The Department of Environment and Health Sciences aims to identify and prevent the negative effect of environmental factors on health.
In particular,it aims to verify the exposure of the population to chemical substances and to assess its risk using in silico and in vitro toxicity studies, analyticalt echniques of mass spectrometry and epidemiology. Furthermore, the effects of drugs diffused in the environment and the consumption of drugs of abuse are also analyzed, through their identification and their measurement in urban wastewater.
PARC – Partnership for the Assessment of Risks from Chemicals.
Sponsor: European Commission
Area of Research: In silico toxic effect modeling, wastewater monitoring and risk assessment
sOFT-ERA - Strengthen OpenFoodTox development for the Evaluation and Risk Assessment of substances
Sponsor: European Food Safety Authority
Area of Research: Risk assessment, database
PollinERA – Understanding pesticide-Pollinator interactions to support EU Environmental Risk Assessment and policy
Sponsor: European Commission
Area of Research: In silico modelling of effects on pollinators
ALTERNATIVE. Building the Innovative Platform for Detecting the Cardiotoxicity of Chemicals
Sponsor: European Commission
Area of Research: In silico toxic effect modelling and risk assessment
nPETS - Nanoparticle emissions from the transport sectors
Sponsor: European Commission
Area of Research: Nanoparticulates and traffic risk assessment
ONTOX - Ontology-driven and artificial intelligence- of based repeated dose toxicity testing chemicals for next generation risk assessment
Sponsor: European Commission
Area of Research: Alternative methods of assessing organo specific toxicity (liver, kidney and central nervous system)
PREMIER - Prioritisation and Risk Evaluation of Medicines in the EnviRonment
Sponsor: European Commission
Area of Research: Ecotoxicological impact of drugs in the environment
OBERON - An iterative strategy of testing systems for identification of EDs related to metabolic disorders
Sponsor: European Commission
Area of Research: Impact of endocrine disrupters on health
The Research Center for Amyotrophic Lateral Sclerosis (ALS Center) brings together the groups that are involved in ALS research from an epidemiological, preclinicaland translational point of view.